A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients.

J Hepatol · 2022 · PMC9015954 · PMID 35452692

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Due to the small sample size and the highly significant response to the third dose among the LT recipients (98.4%), predictors of negative immune response after the third dose could not be evaluated.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.